Alzheimer's disease (AD) is a progressive incurable neurodegenerative disease and a major health problem in aging population. We show that the combined use of Laser-Induced Breakdown Spectroscopy (LIBS) and machine learning applied for the analysis of micro-drops of plasma samples of AD and healthy controls (HC) yields robust classification. Following the acquisition of LIBS spectra of 67 plasma samples from a cohort of 31 AD patients and 36 healthy controls (HC), we successfully diagnose late-onset AD (> 65 years old), with a total classification accuracy of 80%, a specificity of 75% and a sensitivity of 85%.
ASJC Scopus subject areas
- Analytical Chemistry
- Atomic and Molecular Physics, and Optics